Article
European Commission authorizes GSK's HIV prevention drug
Rating:
0.0
Views:
45
Likes:
1
Library:
1
The European Commission has granted authorization to GSK's HIV-focused division, ViiV Healthcare, for its cabotegravir in both long-acting injectable and tablet forms.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value